anti-p53, pAb

CHF 322.00
In stock
YIF-LF-PA0050100 µlCHF 322.00
More Information
Product Details
Synonyms P53; TP53; Antigen NY-CO-13; Phosphoprotein p53; Tumor Suppressor p53; Cellular Tumor Antigen p53
Product Type Polyclonal Antibody
Properties
Immunogen/Antigen Synthetic peptide.
Application

Western Blot (1:2,000)

Crossreactivity Human
Mouse
Rat
Purity Detail Affinity purification.
Formulation Liquid. HEPES with 0.15M NaCl, 0.01% BSA, 0.03% sodium azide, and 50% glycerol.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by AbFrontier
Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Documents
MSDS No
Product Specification Sheet
Datasheet Download PDF

p53 is a transcription factor that regulates the cell cycle and hence functions as a tumor suppressor. p53 has been described as "the guardian of the genome", referring to its role in conserving stability by preventing genome mutation. p53 has many anti-cancer mechanisms: activating DNA repair proteins when DNA has sustained damage, holding the cell cycle at the G1/S regulation point on DNA damage recognition, initiating apoptosis if the DNA damage proves to be irrepairable. Human p53 is 393 amino acids long and has three domains: 1) N-terminal transcription-activation domain (TAD), which activates transcription factors; 2) central DNA-binding core domain (DBD); 3) C-terminal homo-oligomerisation domain (OD). Tetramerization greatly increases the activity of p53 in vivo. Mutations that deactivate p53 in cancer usually occur in the DBD and most of these mutations destroy the ability of the protein to bind to its target DNA sequences Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Cancer induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Implicated in Notch signaling cross-over.

Product References

1) Strachan T, Read AP. (1999). Human Molecular Genetics 2. Ch.18, Cancer Genetics. (General)
2) McCormick F (2001) Nat Rev Cancer. vol.1(2): pp.130-41. (General)
3) Vogelstein B. et al, (2000) Nature. vol.408(6810): pp.307-10. (General)
4) Blagosklonny MV. (2002) Int J Cancer. vol. 98(2): pp.161-6. (General)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.